Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Nrf2 Activation on Macrovascular Function, Microvascular Function, Leg Function, and Walking Capacity in Patients With Peripheral Artery Disease

NCT06319339 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT06319339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06319339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Nrf2 Activation on Macrovascular Function, Microvascular Function, Leg Function, and Walking Capacity in Patients With Peripheral Artery Disease
Lead sponsor
University of Nebraska
Phase
Phase 1
Overall status
Recruiting
Start date
November 14, 2024
Completion date
December 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease, peripheral arterial occlusive disease, peripheral artery disease, peripheral vascular diseases